Q4 2023 Holdings
Filed 2024-02-13 | 119 holdings | $31.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alphabet Inc(GOOG) | Common | 02079K107 | $15.8M | 112,220 | 50.3% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $8.6M | 1,380,000 | 27.2% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | Common | 14888U101 | $2.1M | 125,450 | 6.7% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $1.8M | 526,312 | 5.6% |
| Abeona Therapeutics Inc.(ABEO) | Common | 00289Y206 | $993.0K | 198,300 | 3.2% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $781.0K | 5,037 | 2.5% |
| Corteva, Inc.(CTVA) | Common | 22052L104 | $554.0K | 11,563 | 1.8% |
| Bridgebio Pharma, Inc.(BBIO) | Common | 10806X102 | $484.0K | 12,000 | 1.5% |
| Calumet Specialty Products Partners, LP | Common | 131476103 | $77.3K | 4,325,000 | 0.2% |
| Heritage Nola Bancorp, Inc.(HRGG) | Common | 42727P108 | $56.0K | 3,000 | 0.0% |
| Amazon.com Inc.(AMZN) | Common | 023135106 | $46.0K | 300 | 0.1% |
| Alphabet Inc CL A(GOOGL) | Common | 02079K305 | $42.0K | 300 | 0.1% |
| Danaher Corporation(DHR) | Common | 235851102 | $42.0K | 180 | 0.1% |
| Adobe(ADBE) | Common | 00724F101 | $21.0K | 35 | 0.1% |
| Apollo Global Management, Inc.(APO) | Common | 03769M106 | $21.0K | 225,000 | 0.1% |
| Ftai Aviation Ltd.(FTAI) | Common | G3730V105 | $19.7K | 425,000 | 0.1% |
| The Panagram Bbb-B CLO ETF(CLOZ) | Common | 81752T528 | $19.0K | 719,368 | 0.1% |
| ConocoPhillips(COP) | Common | 20825C104 | $13.0K | 113 | 0.0% |
| DocGo, Inc.(DCGO) | Common | 256086109 | $10.8K | 1,925,000 | 0.0% |
| Ligand Pharmaceuticals Incorporated(LGND) | Common | 53220K504 | $8.2K | 115,000 | 0.0% |
| The Invesco AAA Floating Rate Note ETF(ICLO) | Common | 46090A721 | $7.8K | 307,019 | 0.0% |
| OmniAb Inc.(OABI) | Common | 68218J103 | $6.7K | 1,086,505 | 0.0% |
| Viking Therapeutics, Inc.(VKTX) | Common | 92686J106 | $5.0K | 270,822 | 0.0% |
| Janus Henderson AAA CLO ETF(JAAA) | Common | 47103U845 | $4.7K | 93,647 | 0.0% |
| JPMorgan Chase & Co.(JPM) | Common | 46625H100 | $3.6K | 20,985 | 0.0% |
| Avadel Pharmaceuticals plc | Common | 05337M104 | $3.6K | 251,850 | 0.0% |
| Madrigal Pharmaaceuticals, Inc.(MDGL) | Common | 558868105 | $3.4K | 14,800 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $2.8K | 97,537 | 0.0% |
| CSX Corporation(CSX) | Common | 126408103 | $2.4K | 70,000 | 0.0% |
| GSK plc(GSK) | Common | 37733W204 | $2.4K | 65,000 | 0.0% |
| Inozyme Pharma, Inc. | Common | 45790W108 | $2.4K | 564,549 | 0.0% |
| The Panagram AAA CLO ETF(CLOX) | Common | 81752T486 | $2.4K | 92,956 | 0.0% |
| Sanofi(SNY) | Common | 80105N105 | $2.3K | 47,000 | 0.0% |
| Travere Therapeutics, Inc.(TVTX) | Common | 89422G107 | $2.0K | 221,005 | 0.0% |
| Cenovus Energy Inc.(CVE) | Common | 15135U109 | $1.6K | 95,000 | 0.0% |
| Janus Henderson AAA CLO ETF | Common | 471034845 | $1.6K | 31,432 | 0.0% |
| AllianceBernstein Holding L.P.(AB) | Common | 01881G106 | $1.5K | 49,000 | 0.0% |
| Ryman Hospitality Properties, Inc.(RHP) | Common | 78377T107 | $1.3K | 12,000 | 0.0% |
| Vertex Pharmaceuticals, Inc.(VRTX) | Common | 92532F100 | $1.2K | 3,000 | 0.0% |
| Protagonist Therapeutics, Inc(PTGX) | Common | 74366E102 | $1.2K | 52,368 | 0.0% |
| Xenon Pharmaceuticals Inc.(XENE) | Common | 98420N105 | $1.1K | 23,866 | 0.0% |
| Mondelez International, Inc.(MDLZ) | Common | 609207105 | $1.0K | 14,000 | 0.0% |
| Xeris Biopharma Holdings, Inc.(XERS) | Common | 98422E103 | $912 | 387,910 | 0.0% |
| Evolus, Inc.(EOLS) | Common | 30052C107 | $769 | 73,066 | 0.0% |
| DuPont de Nemours, Inc.(DD) | Common | 26614N102 | $764 | 9,930 | 0.0% |
| Kimberly-Clark Corporation(KMB) | Common | 494368103 | $729 | 6,000 | 0.0% |
| Verona Pharma Plc.(VRNA) | Common | 925050106 | $650 | 32,672 | 0.0% |
| Syros Pharmaceutical, Inc(SYRS) | Common | 87184Q206 | $623 | 79,927 | 0.0% |
| Dow Inc.(DOW) | Common | 260557103 | $611 | 11,136 | 0.0% |
| Microsoft Corporation(MSFT) | Common | 594918104 | $602 | 1,600 | 0.0% |